Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tolerance, Danger, and the Extended Family
Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,820 · cited 1×
“proposed that the immune system has evolved to detect ‘‘danger’’ by employing professional antigen-presenting cells (APC) as sentinels of tissue distress, and in this hypothesis one of the danger signals is one or more HSP [4, 10].”
BackgroundLindquist, S. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.005443 · Cited by 4,588
Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells
Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., Taidi, B., Engleman, E. G., & Levy, R. (1996) · Nature Medicine · doi:10.1038/nm0196-52 · Cited by 1,804 · cited 5×
“The black, blue, and red arrows indicate a blood vessel, a macrophage and a CD8+ cell, respectively. d Histological analysis of HSP70 and APC.”
BackgroundInfluentialAsea, A., Kraeft, S.-K., Kurt-Jones, E. A., Stevenson, M. A., Chen, L. B., Finberg, R. W., Koo, G. C., & Calderwood, S. K. (2000) · Nature Medicine · doi:10.1038/74697 · Cited by 1,620
Schlesinger, M. J. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38314-0 · Cited by 1,355
Basu, S., Binder, R. J., Suto, R., Anderson, K. M., & Srivastava, P. K. (2000) · International Immunology · doi:10.1093/intimm/12.11.1539 · Cited by 1,305 · cited 1×
“Basu et al. reported that necrotic, but not apoptotic, cell death leads to the release of biologically potent HSP from cells [ 3 ].”
BackgroundHeating the patient: a promising approach?
van der Zee, J. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf280 · Cited by 1,220
Roles of heat-shock proteins in innate and adaptive immunity.
Srivastava, P. (2002) · Nature reviews. Immunology · doi:10.1038/nri749 · Cited by 1,069 · cited 1×
“reported that the constitutive HSP70 served as an effective vaccine [26, 27, 28].”
BackgroundSrivastava, P. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064801 · Cited by 850 · cited 1×
“reported that the constitutive HSP70 served as an effective vaccine [26, 27, 28].”
BackgroundA Mechanism for the Specific Immunogenicity of Heat Shock Protein-Chaperoned Peptides
Suto, R., & Srivastava, P. K. (1995) · Science · doi:10.1126/science.7545313 · Cited by 823 · cited 1×
“by exogenous antigens chaperoned by HSP, a pathway that is functional in a subset of macrophages [ 32 ].”
Background
Cited by
Reddy, L. H., Arias, J. L., Nicolas, J., & Couvreur, P. (2012) · Chemical Reviews · doi:10.1021/cr300068p · Cited by 2,010
Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery
Kumar, C. S. S. R., & Mohammad, F. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.03.008 · Cited by 1,666
Medical application of functionalized magnetic nanoparticles
Ito, A., Shinkai, M., Honda, H., & Kobayashi, T. (2005) · Journal of Bioscience and Bioengineering · doi:10.1263/jbb.100.1 · Cited by 1,470
Self-citationBiomedical Nanomagnetics: A Spin Through Possibilities in Imaging, Diagnostics, and Therapy
Krishnan, K. M. (2010) · IEEE Transactions on Magnetics · doi:10.1109/tmag.2010.2046907 · Cited by 819
Nanomaterials as photothermal therapeutic agents
Chen, J., Ning, C., Zhou, Z., Yu, P., Zhu, Y., Tan, G., & Mao, C. (2019) · Progress in Materials Science · doi:10.1016/j.pmatsci.2018.07.005 · Cited by 749
Mahmoudi, K., Bouras, A., Bozec, D., Ivkov, R., & Hadjipanayis, C. (2018) · International Journal of Hyperthermia · doi:10.1080/02656736.2018.1430867 · Cited by 414
Deng, X., Li, K., Cai, X., Liu, B., Wei, Y., Deng, K., Xie, Z., Wu, Z., Ma, P., Hou, Z., et al. (2017) · Advanced Materials · doi:10.1002/adma.201701266 · Cited by 304
Gamarra, L., Silva, A. C., Oliveira, T. R., Mamani, J. B., Malheiros, S. M. F., Malavolta, L., Pavon, L. F., Sibov, T. T., Amaro Jr, E., & Gamarra, L. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s14737 · Cited by 294
Ito, A., Honda, H., & Kobayashi, T. (2006) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-005-0049-y · Cited by 274
Self-citationOptimizing Magnetic Nanoparticle Design for Nanothermotherapy
Gazeau, F., Lévy, M., & Wilhelm, C. (2008) · Nanomedicine · doi:10.2217/17435889.3.6.831 · Cited by 258
Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy
Adkins, I., Fucikova, J., Garg, A. D., Agostinis, P., & Špíšek, R. (2014) · OncoImmunology · doi:10.4161/21624011.2014.968434 · Cited by 200
“The group of Kobayashi has developed a HT system based on liposomes containing magnetic nanoparticles which caused necrotic tumor cell death and the release of HSP70, thereby stimulating an antitumor immune response in vivo.(115,116) Recently, magnet-mediated HT at high therapeutic temperatures (50–55 C) was shown to…”
BackgroundJohannsen, M., Thiesen, B., Jordan, A., Taymoorian, K., Gneveckow, U., Waldöfner, N., Scholz, R., Koch, M., Lein, M., Jung, K., et al. (2005) · The Prostate · doi:10.1002/pros.20213 · Cited by 200
“Other groups have evaluated similar techniques of magnetically mediated hyperthermia using nanoscaled magnetites in animal models of melanoma [21], glioma [22], and breast tumors [23].”
BackgroundGrauer, O., Jaber, M., Hess, K., Weckesser, M., Schwindt, W., Maring, S., Wölfer, J., & Stummer, W. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-03005-x · Cited by 181
Metadata
- Authors
- Ito, A., Shinkai, M., Honda, H., Yoshikawa, K., Saga, S., Wakabayashi, T., Yoshida, J., & Kobayashi, T.
- Venue
- Cancer Immunology, Immunotherapy
- Published
- 2003-02
- Volume
- 52
- Issue
- 2
- Pages
- 80-88
- ISSN
- 0340-7004 (ISSN-L)
- 1432-0851
- OpenAlex
- W1497001479
- Cited by
- 174
- References
- 29
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.